Emerging deep learning (DL) models could improve cardiac image analysis by capturing anatomy, function and motion more effectively than traditional convolutional neural networks, say researchers, who add that clinical validation is still needed before these tools can be widely used in practice. 

Patients with large-vessel occlusion stroke had comparable thrombectomy outcomes whether treated in single-plane or biplane angiography suites, researchers say in a new study. 

Patients who start dual antiplatelet therapy (DAPT) within 6 hours, plus being treated with intravenous thrombolysis, for stroke have better functionality 3 months later, data from the TAPIS randomized clinical trial show. 

Patients with persistent atrial fibrillation (AF) and markedly enlarged left atria have similar long-term outcomes whether treated with pulmonary vein isolation (PVI) or conduction system pacing (CSP) combined with atrioventricular node ablation (AVNA), according to a new prospective observational study. 

Fewer women are undergoing transcatheter aortic valve implantation (TAVI) and they have more complications after TAVI, but higher chances of long-term survival, compared with men, a new study comparing sex outcomes in TAVI shows. 

Periaortic adipose tissue (PAAT) attenuation may be used as a modifiable imaging marker for post-transcatheter aortic valve replacement (TAVR) risk, researchers on a retrospective multicenter cohort study concluded. 

Same day discharge (SDD) following mitral transcatheter edge-to-edge repair (M-TEER) carries a similar 90-day readmission risk as an overnight stay, but with lower index hospitalization costs, a new wide-scale registry study reveals.  

Patients with atrial fibrillation (AF) who experience coronary embolism may represent a distinct, high-risk form of acute myocardial infarction (AMI), characterized by inferior long-term outcomes and substantial residual stroke risk despite anticoagulation, according to experts. 

Patients with premature coronary artery disease (CAD) are adhering to high-intensity lipid-lowering therapy (LLT) in the short-term, 17-year data show, but long-term strategies are needed to promote continued medication use in these patients to prevent cardiac events like heart attack and stroke.